Analyzing the impact of machine learning and artificial intelligence and its effect on management of lung cancer detection in covid-19 pandemic.

Cancer victims, particularly those with lung cancer, are more susceptible and at higher danger of COVID-19 and associated consequences as a result of their compromised immune systems, which makes them particularly sensitive. Because of a variety of circumstances, cancer patients' diagnosis, treatment, and aftercare are very complicated and time-consuming during an epidemic. In such circumstances, advances in artificial intelligence (AI) and machine learning algorithms (ML) offer the capacity to boost cancer sufferer diagnosis, therapy, and care via the use of cutting technologies. For example, using clinical and imaging data combined with machine learning methods, the researchers may be able to distinguish among lung alterations induced by corona virus and those produced by immunotherapy and radiation. During this epidemic, artificial intelligence (AI) may be utilized to guarantee that the appropriate individuals are recruited in cancer clinical trials more quickly and effectively than in the past, which was done in a conventional and complicated manner. In order to better care for cancer patients and find novel and more effective therapies, It is critical that we move beyond traditional research methods and use artificial intelligence (AI) and machine learning to update our research (ML). Artificial intelligence (AI) and machine learning (ML) are being utilised to help with several aspects of the COVID-19 epidemic, such as epidemiology, molecular research and medication development, medical diagnosis and treatment, and socioeconomics. The use of artificial intelligence (AI) and machine learning (ML) in the diagnosis and treatment of COVID-19 patients is also being investigated. The combination of artificial intelligence and machine learning in COVID-19 may help to identify positive patients more quickly. In order to understand the dynamics of an epidemic that is relevant to artificial intelligence, when used in different patient groups, AI-based algorithms can quickly detect CT scans with COVID-19 linked pneumonia, as well as discriminate non-COVID connected pneumonia with high specificity and accuracy. It is possible to utilize the existing difficulties and future views presented in this study to guide an optimal implementation of AI and machine learning technologies in an epidemic.